Priority Date: 16.07.12 (US 201261671963P)

RNAI PHARMACEUTICAL COMPOSITION CAPABLE OF SUPPRESSING EXPRESSION OF KRAS GENE

  • Application ID: EP13820367
  • Status: GRANT OF PATENT INTENDED

Attorney

Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 16.07.2012 - Priority Date (US 201261671963P)
  • 23.01.2014 - Publication A1 (WO2014013995)
  • 20.05.2015 - Publication A1 (EP2873732)

IPC Classification